Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
5 studies found for:    7680764 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Adoptive Cell Therapy for B-Cell Cancers in Patients After Stem Cell Transplantation
Condition: Chronic Lymphocytic Leukemia
Intervention: Drug: Allogeneic Cell Therapy w/ Tumor-derived Lypho
2 Recruiting R-CHOP Versus R-CDOP as First-line Treatment for Elderly Patients With Diffuse Large-B-cell Lymphoma
Condition: Lymphoma, Large B-Cell, Diffuse
Interventions: Drug: Pegylated liposomal doxorubicin;   Drug: Doxorubicin;   Drug: Rituximab;   Drug: Cyclophophamide;   Drug: Vincristine;   Drug: Prednisone
3 Recruiting Prospective Observational Study Investigating the Cardiotoxicity of Anthracyclines in Patients With Diffuse Large B-Cell
Conditions: Lymphoma;   Large B-Cell;   Diffuse Large B-Cell
Intervention: Drug: R-CHOP with doxorubicin
4 Active, not recruiting Tailoring Treatment for B Cell Non-hodgkin's Lymphoma Based on PET Scan Results Mid Treatment
Conditions: Lymphoma, Non-Hodgkin;   Advanced Stage Diffuse Large B-Cell Non-Hodgkin's Lymphoma
Interventions: Drug: Cyclophosphamide;   Drug: Doxorubicin;   Drug: Vincristine;   Drug: Prednisone;   Drug: Ondansetron;   Drug: Dexamethasone;   Drug: Diphenhydramine;   Drug: Acetaminophen;   Drug: Ifosfamide;   Drug: Mesna (IV);   Drug: Mesna (oral);   Drug: Carboplatin;   Drug: Etoposide;   Drug: Rituximab;   Other: PET Scan
5 Completed Genetic Determinations for Side Effects and Response Rate for Patients Receiving Chemotherapy With Diffuse Large Cell Lymphoma
Conditions: Lymphoma;   Diffuse Large Cell
Intervention: Procedure: Blood draw

Study has passed its completion date and status has not been verified in more than two years.